
Former EVP and President, Global Pharmaceuticals
Schering-Plough2009 Total compensation: $23 million*
Source: Equilar Inc.
NEXT: Irene Rosenfeld
Last updated September 29 2010: 6:17 AM ET
* Cox ceased serving in her position following the merger between Merck & Co. and Schering-Plough. 2009 total compensation includes $17,576,548 in severance related payments.
Note: Total compensation includes annualized base salary, discretionary and performance-based bonus payouts, the grant-date fair value of new stock and option awards and other compensation. If relevant, other compensation includes severance payments. Equilar Inc., an executive compensation research firm in Redwood Shores, Calif., prepared the chart by looking at companies with more than $1 billion in revenues that filed proxies by Aug. 15.
Note: Total compensation includes annualized base salary, discretionary and performance-based bonus payouts, the grant-date fair value of new stock and option awards and other compensation. If relevant, other compensation includes severance payments. Equilar Inc., an executive compensation research firm in Redwood Shores, Calif., prepared the chart by looking at companies with more than $1 billion in revenues that filed proxies by Aug. 15.
